BioInvent International
BioInvent: Interview with CEO Martin Welschof and CMO Andres McAllister about ESMO and BI-1808 (Redeye)

2024-09-11 13:30
Redeye interviews CEO Martin Welschof, and CMO Andres McAllister, about the progress with BT-001 (oncolytic virus) and BI-1910 presented at ESMO. We also discuss the recent BI-1808 data in cutaneous t-cell lymphoma (CTCL).

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

BioInvent International - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -